NCT00569712: Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol |
|
|
| Completed | 1 | 30 | Canada | budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization, microarray analysis, bronchoalveolar lavage, immunoenzyme technique, laboratory biomarker analysis, bronchoscopy | British Columbia Cancer Agency, AstraZeneca | Lung Cancer, Precancerous Condition | 12/08 | 12/08 | | |
NCT01257048: Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler |
|
|
| Completed | 1 | 34 | Europe | Formoterol Turbuhaler, Budesonide/Formoterol Turbuhaler | AstraZeneca | COPD Method Evaluation, Chronic Obstructive Pulmonary Disease Method Evaluation | 06/12 | 06/12 | | |
